JAZZ
Jazz Pharmaceuticals plcHealthcare · $14.5B market cap
Verdict
Share price
$235.67
close of Oct 3, 2026
Fair value
$143.36
Sticker Price
Payback Price
$57.34
buy price
JAZZ is Overpriced: at $235.67 it trades 64% above its fair value of $143.36. Its buy price (Payback Price) is $57.34, 76% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew 5% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
3 of 5 clear the 10% bar. What are the Big Five?
Follow JAZZ
Get notified when it reaches its buy price of $57.34. Free.
Create a free accountSuperinvestors
2 of the investors we track hold JAZZ. In Q2 2026, 1 opened a position and 1 sold out. Who we track
Insider activity
Since Jun 15, 2026: no open-market purchases, 11 sales worth $24.4M and 46 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
GALA RENEE D
President & CEO · 2026-09-08
Sold
$486K
COZADD BRUCE C
director · 2026-09-01
Sold
$1.5M
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Sold
$76K
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Sold
$2.3M
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Sold
$4.9M
Show all 11 salesShow fewer
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Sold
$4.5M
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Sold
$2.8M
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Sold
$4.5M
COZADD BRUCE C
director · 2026-08-03
Sold
$1.5M
COZADD BRUCE C
director · 2026-07-01
Sold
$1.4M
Smith Mark Douglas
director · 2026-06-15
Sold
$267K
Other filings
Henderson Mary Elizabeth
SVP, Technical Operations · 2026-09-08
Tax withholding
$4K
Henderson Mary Elizabeth
SVP, Technical Operations · 2026-09-08
Tax withholding
$343K
GALA RENEE D
President & CEO · 2026-09-08
Tax withholding
$485K
COZADD BRUCE C
director · 2026-08-31
Tax withholding
$292K
COZADD BRUCE C
director · 2026-08-31
Tax withholding
$2K
Show all 46 other filingsShow fewer
Winningham Rick E
director · 2026-08-31
Tax withholding
$3K
Winningham Rick E
director · 2026-08-31
Tax withholding
$408K
Kennedy Patrick
director · 2026-08-31
Tax withholding
$444K
Kennedy Patrick
director · 2026-08-31
Tax withholding
$4K
McSharry Heather Ann
director · 2026-08-31
Tax withholding
$444K
McSharry Heather Ann
director · 2026-08-31
Tax withholding
$4K
ENRIGHT PATRICK G
director · 2026-08-31
Tax withholding
$408K
ENRIGHT PATRICK G
director · 2026-08-31
Tax withholding
$3K
Cook Jennifer E.
director · 2026-08-31
Tax withholding
$408K
Cook Jennifer E.
director · 2026-08-31
Tax withholding
$3K
Hamill Laura
director · 2026-08-31
Tax withholding
$408K
Hamill Laura
director · 2026-08-31
Tax withholding
$3K
LOVE TED W
director · 2026-08-31
Tax withholding
$178K
LOVE TED W
director · 2026-08-31
Tax withholding
$1K
RIEDEL NORBERT G
director · 2026-08-31
Tax withholding
$408K
RIEDEL NORBERT G
director · 2026-08-31
Tax withholding
$3K
Smith Mark Douglas
director · 2026-08-31
Tax withholding
$408K
Smith Mark Douglas
director · 2026-08-31
Tax withholding
$3K
Henderson Mary Elizabeth
SVP, Technical Operations · 2026-08-31
Tax withholding
$4K
Henderson Mary Elizabeth
SVP, Technical Operations · 2026-08-31
Tax withholding
$501K
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Option exercise
$3.0M
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Option exercise
$100K
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Option exercise
$3.8M
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-08-27
Option exercise
$400K
COZADD BRUCE C
director · 2026-08-05
Award
1,605 shares
RIEDEL NORBERT G
director · 2026-08-05
Award
1,605 shares
ENRIGHT PATRICK G
director · 2026-08-05
Award
1,605 shares
McSharry Heather Ann
director · 2026-08-05
Award
1,605 shares
Mulligan Seamus
director · 2026-08-05
Award
1,605 shares
Cook Jennifer E.
director · 2026-08-05
Award
1,605 shares
Smith Mark Douglas
director · 2026-08-05
Award
1,605 shares
Kennedy Patrick
director · 2026-08-05
Award
1,605 shares
Hamill Laura
director · 2026-08-05
Award
1,605 shares
LOVE TED W
director · 2026-08-05
Award
1,605 shares
Winningham Rick E
director · 2026-08-05
Award
1,605 shares
Pearce Samantha
EVP, Chief Commercial Officer · 2026-08-05
Tax withholding
$204K
Johnson Philip L
EVP & Chief Financial Officer · 2026-06-30
Tax withholding
$795K
Patil Neena M
EVP & Chief Legal Officer · 2026-06-30
Tax withholding
$637K
Iannone Robert
EVP, Global Head of R&D & CMO · 2026-06-30
Tax withholding
$895K
GALA RENEE D
President & CEO · 2026-06-30
Tax withholding
$1.1M
Pearce Samantha
EVP, Chief Commercial Officer · 2026-06-30
Tax withholding
$601K
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works